Pfizer Stock News

The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.

Pfizer Inc. shares PFE, -0.08% gained 1.5% premarket on Wednesday after the company reported first-quarter profit and sales that beat analyst expectations, boosted by strong sales of its Vyndaqel fami

Pfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the American pharmaceutical giant attempts to regain its footing as the COVID-19 pandemic subsides.

Pfizer Inc. (NYSE: PFE) has announced its financial outcomes for the first quarter of 2024, displaying strong performance in its non-COVID product portfolio. This includes heightened revenues from rec

Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and respiratory synctitial virus vaccines.

Everyone needs solace in stability and development in the current turbulent market climate. These are seven unwavering businesses that are well-known for their fundamental capability to withstand mark

Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.

Microsoft's growth backs up the stock's premium valuation. Pfizer, NextEra Energy, and Home Depot are industry-leading businesses with quality dividends.

Pfizer faces challenges with declining COVID-19 product sales and upcoming patent expirations for key products. However, the company's valuation, dividend yield, and overall growth prospects remain at

The rise of artificial intelligence (AI) has most of Wall Street seeing big dollar signs. Despite Nvidia's phenomenal growth, three top-tier billionaire investors each sold more than 1 million shares

Pfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer.

Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

This week, 175 companies in the S&P 500 index report quarterly results, making it the busiest for the U.S. earnings reporting season overall. But amid the stampede, much of Wall Street's attention wil

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored) If you want your portfolio to pay you cash like clockwork, it's time to stop blindly following conventional wisdom li